Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | IM |
Rash fluid discharge itchy; Rash fluid discharge itchy; This non-serious case was reported by a other health professional and described the occurrence of pustular rash in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included hypertension and blood cholesterol abnormal. On 09-MAY-2025, the patient received Shingrix (intramuscular) .5 ml. On 09-MAY-2025, less than a day after receiving Shingrix, the patient experienced pustular rash (Verbatim: Rash fluid discharge itchy) and itchy rash (Verbatim: Rash fluid discharge itchy). The outcome of the pustular rash and itchy rash were not resolved. It was unknown if the reporter considered the pustular rash and itchy rash to be related to Shingrix. It was unknown if the company considered the pustular rash and itchy rash to be related to Shingrix. Additional Information: GSK receipt date: 23-MAY-2025 The patient was gardening as well rash fluid discharge itchy. No additional information was reported.
Blood cholesterol abnormal; Hypertension